8 results
DEF 14A
ZNTL
Zentalis Pharmaceuticals Inc
23 Apr 21
Definitive proxy
4:05pm
may also be deemed beneficially owned by Jeremy C. Green as the principal of Redmile Group, LLC. Redmile Group, LLC and Mr. Green have shared voting … and dispositive power over the shares. Redmile Group, LLC and Mr. Green each disclaim beneficial ownership of the shares. The business address
10-K
2020 FY
ZNTL
Zentalis Pharmaceuticals Inc
25 Mar 21
Annual report
7:17am
business, with the goal of being “green chemists,” applying our science in the labs carefully to efficiently use and conserve precious recourses. We
10-K
EX-10.12
vd83zae6miocwp6lc8
25 Mar 21
Annual report
7:17am
DRS
EX-10.11
g5js llvvy9n29mr
10 Jul 20
Draft registration statement
12:00am
S-1
EX-10.11
gbjkdt1pih1o0rik
6 Mar 20
IPO registration
5:05pm
- Prev
- 1
- Next